CN Stock MarketDetailed Quotes

300294 China Resources Boya Bio-pharmaceutical Group

Watchlist
  • 34.18
  • -0.02-0.06%
Market Closed May 17 15:00 CST
17.24BMarket Cap78.57P/E (TTM)

China Resources Boya Bio-pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-44.36%448.45M
-3.87%2.65B
5.17%2.19B
10.16%1.54B
23.11%805.93M
4.08%2.76B
3.54%2.08B
8.02%1.4B
4.89%654.64M
5.47%2.65B
Operating revenue
-44.36%448.45M
-3.87%2.65B
5.17%2.19B
10.16%1.54B
23.11%805.93M
4.08%2.76B
3.54%2.08B
8.02%1.4B
4.89%654.64M
5.47%2.65B
Other operating revenue
----
138.05%845.92K
----
120.05%623.44K
----
-142.70%-2.22M
----
-151.32%-3.11M
----
54.97%5.21M
Total operating cost
-52.53%301.27M
-6.07%2.09B
6.17%1.75B
12.15%1.23B
22.64%634.66M
2.41%2.22B
1.18%1.65B
2.91%1.09B
1.50%517.5M
-1.86%2.17B
Operating cost
-65.93%144.46M
0.16%1.25B
16.92%1.09B
21.69%772.07M
42.64%424.06M
9.71%1.25B
7.84%935.94M
12.04%634.46M
9.52%297.3M
8.22%1.14B
Operating tax surcharges
-29.07%4.02M
-8.43%20.07M
-6.11%15.7M
3.03%10.73M
16.30%5.66M
9.67%21.92M
22.02%16.72M
16.50%10.41M
11.88%4.87M
2.18%19.99M
Operating expense
-34.36%104.04M
-16.23%582.59M
-12.33%454.12M
-5.47%320.21M
-4.73%158.5M
-9.43%695.45M
-6.81%517.97M
-6.20%338.73M
-9.42%166.36M
-11.18%767.85M
Administration expense
-15.06%37.96M
-15.27%194.85M
0.26%159.98M
2.39%101.01M
-7.47%44.69M
12.96%229.97M
13.05%159.57M
19.06%98.66M
12.25%48.3M
15.94%203.58M
Financial expense
0.34%-8.21M
-20.63%-30.49M
-26.14%-23.11M
-32.30%-16.33M
-32.77%-8.23M
-22.68%-25.28M
-606.60%-18.32M
-600.57%-12.35M
-690.96%-6.2M
-327.69%-20.61M
-Interest expense (Financial expense)
-83.78%18.61K
-26.86%455.59K
-19.97%412K
-20.23%281.61K
-35.65%114.73K
-94.08%622.91K
-93.21%514.8K
-92.43%353.01K
-92.46%178.3K
-50.91%10.53M
-Interest Income (Financial expense)
1.78%-8.27M
-19.44%-31.29M
-24.77%-23.81M
-30.01%-16.75M
-30.42%-8.42M
16.83%-26.2M
-82.00%-19.08M
-94.32%-12.89M
-106.08%-6.46M
-145.66%-31.5M
Research and development
90.36%19.01M
36.54%67.7M
34.85%48.04M
65.56%37.71M
45.32%9.98M
-16.38%49.58M
-31.85%35.63M
-48.68%22.77M
-15.86%6.87M
-33.41%59.29M
Credit Impairment Loss
53.08%-1.69M
27.68%-2.46M
88.39%-719.73K
69.22%-2.51M
38.86%-3.59M
45.00%-3.4M
-481.58%-6.2M
-1,874.24%-8.17M
-408.83%-5.87M
-155.87%-6.18M
Asset Impairment Loss
842.73%660.31K
-526.62%-329.66M
-93.10%64.1K
-70.51%194.02K
-56.44%70.04K
34.82%-52.61M
7,849.82%929.05K
-6.13%657.84K
-85.16%160.81K
-17,008.75%-80.71M
Other net revenue
-19.30%27.56M
-5,128.21%-209.17M
94.06%135.85M
149.84%80.34M
379.34%34.16M
89.23%-4M
646.34%70.01M
208.99%32.16M
-240.23%-12.23M
-224.82%-37.16M
Fair value change income
-46.73%18.52M
1,579.99%85.74M
251.95%75.71M
578.63%59.22M
518.81%34.76M
-52.37%5.1M
--21.51M
---12.37M
---8.3M
--10.71M
Invest income
0.22%1.19M
-63.82%14.01M
-13.88%41.49M
-85.56%6.95M
--1.19M
19.55%38.73M
587.91%48.18M
563.52%48.18M
----
219.47%32.4M
Asset deal income
----
1,798.54%1.3M
748.63%478.75K
101.55%195.92K
-59.27%33.35K
107.87%68.47K
107.23%56.41K
112.64%97.2K
189.28%81.89K
45.06%-870.06K
Other revenue
423.10%8.88M
170.27%21.89M
240.53%18.83M
332.69%16.3M
-0.31%1.7M
8.19%8.1M
30.59%5.53M
36.75%3.77M
57.52%1.7M
-29.55%7.49M
Operating profit
-14.93%174.75M
-33.25%355.23M
14.24%577.18M
17.04%395.82M
64.46%205.42M
20.12%532.18M
28.69%505.26M
38.93%338.19M
1.57%124.91M
33.67%443.06M
Add:Non operating Income
121.58%1.59M
-31.65%3.8M
-25.68%2.34M
-70.50%750.84K
-26.75%719.4K
74.65%5.56M
9.33%3.15M
3.22%2.55M
-39.97%982.09K
-78.99%3.18M
Less:Non operating expense
-79.80%68.87K
-7.40%5.31M
-1.27%4.32M
64.95%2.98M
164.55%340.88K
83.83%5.74M
435.10%4.38M
328.20%1.8M
0.70%128.86K
-83.11%3.12M
Total profit
-14.35%176.27M
-33.51%353.71M
14.12%575.2M
16.13%393.59M
63.64%205.8M
20.06%532M
27.70%504.03M
38.07%338.93M
1.03%125.76M
35.04%443.12M
Less:Income tax cost
-22.01%24.51M
22.02%105.56M
34.59%101.11M
16.30%60.96M
66.20%31.43M
1.97%86.51M
21.41%75.13M
26.69%52.42M
-7.87%18.91M
60.47%84.84M
Net profit
-12.97%151.76M
-44.30%248.15M
10.54%474.09M
16.10%332.63M
63.19%174.37M
24.34%445.49M
28.87%428.9M
40.38%286.51M
2.79%106.85M
30.16%358.28M
Net profit from continuing operation
-12.97%151.76M
-42.86%215.14M
10.54%474.09M
16.10%332.63M
63.19%174.37M
5.09%376.5M
28.87%428.9M
40.38%286.51M
2.79%106.85M
30.16%358.28M
Net income from discontinuing operating
----
-52.15%33.01M
----
----
----
--68.99M
----
----
----
----
Less:Minority Profit
-106.51%-264.04K
-19.62%10.68M
-5.63%10.02M
-12.53%6.71M
22.97%4.06M
-3.34%13.29M
13.65%10.62M
20.19%7.67M
2.40%3.3M
-9.55%13.75M
Net profit of parent company owners
-10.74%152.02M
-45.06%237.47M
10.95%464.07M
16.88%325.92M
64.47%170.32M
25.45%432.2M
29.31%418.28M
41.03%278.84M
2.80%103.55M
32.48%344.53M
Earning per share
Basic earning per share
-11.76%0.3
-45.35%0.47
10.84%0.92
18.18%0.65
61.90%0.34
8.86%0.86
9.21%0.83
19.57%0.55
-12.50%0.21
29.51%0.79
Diluted earning per share
-11.76%0.3
-45.35%0.47
10.84%0.92
18.18%0.65
61.90%0.34
8.86%0.86
9.21%0.83
19.57%0.55
-12.50%0.21
29.51%0.79
Other composite income
14.81M
Other composite income of parent company owners
----
----
----
----
----
----
----
----
----
--14.81M
Total composite income
-12.97%151.76M
-44.30%248.15M
10.54%474.09M
16.10%332.63M
63.19%174.37M
19.41%445.49M
22.58%428.9M
20.98%286.51M
2.84%106.85M
35.54%373.09M
Total composite income of parent company owners
-10.74%152.02M
-45.06%237.47M
10.95%464.07M
16.88%325.92M
64.47%170.32M
20.28%432.2M
22.82%418.28M
21.00%278.84M
2.86%103.55M
38.18%359.34M
Total composite income of minority owners
-106.51%-264.04K
-19.62%10.68M
-5.63%10.02M
-12.53%6.71M
22.97%4.06M
-3.34%13.29M
13.65%10.62M
20.19%7.67M
2.40%3.3M
-9.55%13.75M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -44.36%448.45M-3.87%2.65B5.17%2.19B10.16%1.54B23.11%805.93M4.08%2.76B3.54%2.08B8.02%1.4B4.89%654.64M5.47%2.65B
Operating revenue -44.36%448.45M-3.87%2.65B5.17%2.19B10.16%1.54B23.11%805.93M4.08%2.76B3.54%2.08B8.02%1.4B4.89%654.64M5.47%2.65B
Other operating revenue ----138.05%845.92K----120.05%623.44K-----142.70%-2.22M-----151.32%-3.11M----54.97%5.21M
Total operating cost -52.53%301.27M-6.07%2.09B6.17%1.75B12.15%1.23B22.64%634.66M2.41%2.22B1.18%1.65B2.91%1.09B1.50%517.5M-1.86%2.17B
Operating cost -65.93%144.46M0.16%1.25B16.92%1.09B21.69%772.07M42.64%424.06M9.71%1.25B7.84%935.94M12.04%634.46M9.52%297.3M8.22%1.14B
Operating tax surcharges -29.07%4.02M-8.43%20.07M-6.11%15.7M3.03%10.73M16.30%5.66M9.67%21.92M22.02%16.72M16.50%10.41M11.88%4.87M2.18%19.99M
Operating expense -34.36%104.04M-16.23%582.59M-12.33%454.12M-5.47%320.21M-4.73%158.5M-9.43%695.45M-6.81%517.97M-6.20%338.73M-9.42%166.36M-11.18%767.85M
Administration expense -15.06%37.96M-15.27%194.85M0.26%159.98M2.39%101.01M-7.47%44.69M12.96%229.97M13.05%159.57M19.06%98.66M12.25%48.3M15.94%203.58M
Financial expense 0.34%-8.21M-20.63%-30.49M-26.14%-23.11M-32.30%-16.33M-32.77%-8.23M-22.68%-25.28M-606.60%-18.32M-600.57%-12.35M-690.96%-6.2M-327.69%-20.61M
-Interest expense (Financial expense) -83.78%18.61K-26.86%455.59K-19.97%412K-20.23%281.61K-35.65%114.73K-94.08%622.91K-93.21%514.8K-92.43%353.01K-92.46%178.3K-50.91%10.53M
-Interest Income (Financial expense) 1.78%-8.27M-19.44%-31.29M-24.77%-23.81M-30.01%-16.75M-30.42%-8.42M16.83%-26.2M-82.00%-19.08M-94.32%-12.89M-106.08%-6.46M-145.66%-31.5M
Research and development 90.36%19.01M36.54%67.7M34.85%48.04M65.56%37.71M45.32%9.98M-16.38%49.58M-31.85%35.63M-48.68%22.77M-15.86%6.87M-33.41%59.29M
Credit Impairment Loss 53.08%-1.69M27.68%-2.46M88.39%-719.73K69.22%-2.51M38.86%-3.59M45.00%-3.4M-481.58%-6.2M-1,874.24%-8.17M-408.83%-5.87M-155.87%-6.18M
Asset Impairment Loss 842.73%660.31K-526.62%-329.66M-93.10%64.1K-70.51%194.02K-56.44%70.04K34.82%-52.61M7,849.82%929.05K-6.13%657.84K-85.16%160.81K-17,008.75%-80.71M
Other net revenue -19.30%27.56M-5,128.21%-209.17M94.06%135.85M149.84%80.34M379.34%34.16M89.23%-4M646.34%70.01M208.99%32.16M-240.23%-12.23M-224.82%-37.16M
Fair value change income -46.73%18.52M1,579.99%85.74M251.95%75.71M578.63%59.22M518.81%34.76M-52.37%5.1M--21.51M---12.37M---8.3M--10.71M
Invest income 0.22%1.19M-63.82%14.01M-13.88%41.49M-85.56%6.95M--1.19M19.55%38.73M587.91%48.18M563.52%48.18M----219.47%32.4M
Asset deal income ----1,798.54%1.3M748.63%478.75K101.55%195.92K-59.27%33.35K107.87%68.47K107.23%56.41K112.64%97.2K189.28%81.89K45.06%-870.06K
Other revenue 423.10%8.88M170.27%21.89M240.53%18.83M332.69%16.3M-0.31%1.7M8.19%8.1M30.59%5.53M36.75%3.77M57.52%1.7M-29.55%7.49M
Operating profit -14.93%174.75M-33.25%355.23M14.24%577.18M17.04%395.82M64.46%205.42M20.12%532.18M28.69%505.26M38.93%338.19M1.57%124.91M33.67%443.06M
Add:Non operating Income 121.58%1.59M-31.65%3.8M-25.68%2.34M-70.50%750.84K-26.75%719.4K74.65%5.56M9.33%3.15M3.22%2.55M-39.97%982.09K-78.99%3.18M
Less:Non operating expense -79.80%68.87K-7.40%5.31M-1.27%4.32M64.95%2.98M164.55%340.88K83.83%5.74M435.10%4.38M328.20%1.8M0.70%128.86K-83.11%3.12M
Total profit -14.35%176.27M-33.51%353.71M14.12%575.2M16.13%393.59M63.64%205.8M20.06%532M27.70%504.03M38.07%338.93M1.03%125.76M35.04%443.12M
Less:Income tax cost -22.01%24.51M22.02%105.56M34.59%101.11M16.30%60.96M66.20%31.43M1.97%86.51M21.41%75.13M26.69%52.42M-7.87%18.91M60.47%84.84M
Net profit -12.97%151.76M-44.30%248.15M10.54%474.09M16.10%332.63M63.19%174.37M24.34%445.49M28.87%428.9M40.38%286.51M2.79%106.85M30.16%358.28M
Net profit from continuing operation -12.97%151.76M-42.86%215.14M10.54%474.09M16.10%332.63M63.19%174.37M5.09%376.5M28.87%428.9M40.38%286.51M2.79%106.85M30.16%358.28M
Net income from discontinuing operating -----52.15%33.01M--------------68.99M----------------
Less:Minority Profit -106.51%-264.04K-19.62%10.68M-5.63%10.02M-12.53%6.71M22.97%4.06M-3.34%13.29M13.65%10.62M20.19%7.67M2.40%3.3M-9.55%13.75M
Net profit of parent company owners -10.74%152.02M-45.06%237.47M10.95%464.07M16.88%325.92M64.47%170.32M25.45%432.2M29.31%418.28M41.03%278.84M2.80%103.55M32.48%344.53M
Earning per share
Basic earning per share -11.76%0.3-45.35%0.4710.84%0.9218.18%0.6561.90%0.348.86%0.869.21%0.8319.57%0.55-12.50%0.2129.51%0.79
Diluted earning per share -11.76%0.3-45.35%0.4710.84%0.9218.18%0.6561.90%0.348.86%0.869.21%0.8319.57%0.55-12.50%0.2129.51%0.79
Other composite income 14.81M
Other composite income of parent company owners --------------------------------------14.81M
Total composite income -12.97%151.76M-44.30%248.15M10.54%474.09M16.10%332.63M63.19%174.37M19.41%445.49M22.58%428.9M20.98%286.51M2.84%106.85M35.54%373.09M
Total composite income of parent company owners -10.74%152.02M-45.06%237.47M10.95%464.07M16.88%325.92M64.47%170.32M20.28%432.2M22.82%418.28M21.00%278.84M2.86%103.55M38.18%359.34M
Total composite income of minority owners -106.51%-264.04K-19.62%10.68M-5.63%10.02M-12.53%6.71M22.97%4.06M-3.34%13.29M13.65%10.62M20.19%7.67M2.40%3.3M-9.55%13.75M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --KPMG Huazhen Certified Public Accountants (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg